Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Guanzhi Chen
Qingdao University
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
62
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety and Efficacy of Anti-PD-1/Anti-PD-L1 Therapy in Cancer Patients Living with HIV: A Systematic Review and Meta-Analysis
Number of pages: 27
Posted: 06 Nov 2023
Yue Yuan
,
Wenjing Wang
,
Wenjiao Zhu
,
Yang Zhang
,
Jiaze He
,
Xiaoran Ma
,
Xinchao Liu
,
Hao Wu
,
Huachun Zou
,
Tong Zhang
, Guanzhi Chen and
Xiaojie Huang
Qingdao University, Capital Medical University - Department of Infectious Diseases, Qingdao University, Capital Medical University - Department of Infectious Diseases, Government of the People's Republic of China - China-Japan Friendship Hospital, Tianjin University, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Capital Medical University - Department of Infectious Diseases, Sun Yat-sen University (SYSU) - School of Public Health, Capital Medical University - Clinical and Research Center for Infectious Diseases, Qingdao University and Capital Medical University - Clinical and Research Center for Infectious Diseases
Downloads
62
(760,031)
View PDF
Download
Abstract:
HIV, AIDS, nivolumab, pembrolizumab, avelumab, atezolizumab, durvalumab, anti-PD-1, anti-PD-L1
Feedback